Inhibition of Bruton's tyrosine kinase selectively prevents antigen-activation of B cells and ameliorates B cell-mediated experimental autoimmune encephalomyelitis

被引：0
|
作者：
Torke, S. [1 ]
Greeningloh, R. [2 ]
Boschert, U. [2 ]
Weber, M. [3 ,4 ]
机构：
[1] Inst Neruopathol, Editorial, Gottingen, Germany
[2] EMD Serono Res & Dev Inst, Billerica, MA USA
[3] Univ Med Ctr, Inst Neuropathol, Gottingen, Germany
[4] Univ Med Ctr Gottingen, Dept Neurol, Gottingen, Germany
来源：
MULTIPLE SCLEROSIS JOURNAL | 2018年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P575
引用
收藏
页码：276 / 276
页数：1
相关论文
共 50 条
  • [1] Inhibition of Bruton's tyrosine kinase selectively prevents antigen-activation of B cells and ameliorates B cell-mediated experimental autoimmune encephalomyelitis
    Torke, S.
    Haeusler, D.
    Grenningloh, R.
    Boschert, U.
    Brueck, W.
    Weber, M.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 513 - 514
  • [2] Inhibition of Bruton's Tyrosine Kinase Selectively Prevents Antigen-Activation B cells and Ameliorates B-Cell-Mediated Experimental Autoimmune Encephalomyelitis
    Torke, Sebastian
    Grenningloh, Roland
    Brueck, Wolfgang
    Boschert, Ursula
    Weber, Martin
    NEUROLOGY, 2019, 92 (15)
  • [3] Inhibition Of Bruton's Tyrosine Kinase Selectively Prevents Antigen Activation Of B Cells And Ameliorates B-Cell-Mediated Experimental Autoimmune Encephalomyelitis
    Torke, S.
    Pretzsch, R.
    Haeusler, D.
    Grenningloh, R.
    Boschert, U.
    Brueck, W.
    Weber, M. S.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (1_SUPPL) : 60 - 61
  • [4] Evobrutinib, a highly selective btk inhibitor, prevents antigen-activation of b cells and ameliorates experimental autoimmune encephalomyelitis
    Torke, S.
    Pretzsch, R.
    Haeusler, D.
    Grenningloh, R.
    Boschert, U.
    Brueck, W.
    Weber, M.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 281 - 281
  • [5] B cell-mediated experimental CNS autoimmunity is modulated by inhibition of Bruton's tyrosine kinase
    Torke, S.
    Grenningloh, R.
    Boschert, U.
    Weber, M. S.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 42 - 43
  • [6] A Bruton's Tyrosine Kinase Inhibitor Prevents Antigen-Driven B Cell Activation In Vivo
    Benson, Micah
    Rodriguez, Varenka A.
    Andreyeva, Tatyana
    Keegan, Sean
    Springer, John R.
    Schnute, Mark E.
    Dunussi-Joannopoulos, Kyri
    Nickerson-Nutter, Cheryl L.
    Rankin, Andrew L.
    Ruzek, Melanie
    Douhan, John, III
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S689 - S689
  • [7] The bruton's tyrosine kinase inhibitor evobrutinib ameliorates meningeal inflammation in experimental autoimmune encephalomyelitis
    Kim, S.
    Boschert, U.
    Grenningloh, R.
    Bhargava, P.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 313 - 313
  • [8] Syk and Bruton's tyrosine kinase are required for B cell antigen receptor-mediated activation of the kinase Aht
    Craxton, A
    Jiang, AM
    Kurosaki, T
    Clark, EA
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (43) : 30644 - 30650
  • [9] The Bruton's Tyrosine Kinase Inhibitor Evobrutinib Ameliorates Meningeal Inflammation in Experimental Autoimmune Encephalomyelitis (EAE)
    Kim, Sol
    Boschert, Ursula
    Grenningloh, Roland
    Bhargava, Pavan
    NEUROLOGY, 2020, 94 (15)
  • [10] A Bruton's Tyrosine Kinase inhibitor prevents antigen-driven B cell activation, germinal center persistence and memory B cell re-activation in vivo
    Rodriguez, Varenka
    Springer, John
    Schnute, Mark
    Dunussi-Joannopoulos, Kyri
    Douhan, John
    Ruzek, Melanie
    Benson, Micah
    JOURNAL OF IMMUNOLOGY, 2012, 188
12345